Cleared Traditional

K181658 - MobileECG 2 BT

K181658 is the FDA 510(k) clearance for MobileECG 2 BT by Memtec Corporation. It is a Class 2 Cardiovascular device (product code DSI) cleared through the Traditional 510(k) pathway after a 274-day FDA review.

K181658 · Memtec Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2019
Decision
274d
Days
Class 2
Risk

K181658 is an FDA 510(k) clearance for the MobileECG 2 BT. Classified as Detector And Alarm, Arrhythmia (product code DSI), Class II - Special Controls.

Submitted by Memtec Corporation (Salem, US). The FDA issued a Cleared decision on March 26, 2019 after a review of 274 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Memtec Corporation devices

Submission Details

510(k) Number K181658 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 25, 2018
Decision Date March 26, 2019
Days to Decision 274 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
149d slower than avg
Panel avg: 125d · This submission: 274d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DSI Detector And Alarm, Arrhythmia
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSI Detector And Alarm, Arrhythmia

All 220
Devices cleared under the same product code (DSI) and FDA review panel - the closest regulatory comparables to K181658.
BodyGuardian Remote Monitoring System
K192732 · Preventice Technologies, Inc. · Mar 2020
Patient Assistant Model PA97000
K190574 · Medtronic, Inc. · Sep 2019
Liba3 System
K182532 · National Cardiac, Inc. · May 2019
Medicalgorithmics Unified Cardiac Rehabilitation System
K173969 · Medicalgorithmics S.A. · Jul 2018
Epicardia Anywhere
K173170 · Medicomp, Inc. · Jan 2018
IntelliVue Patient Monitor
K151681 · Philips Medizin Systeme Boeblingen GmbH · Jul 2015